pharmaphorum September 1, 2021
The new Cancer Care in Europe: Recovering from COVID-19 Disruption white paper assesses the disruption to patient care and the changes physicians implemented during the acute phase of the pandemic, with a focus on the way in which treatment strategies were altered.
The publication, which has been supported by Accord Healthcare, also provides a series of recommendations for how the pharmaceutical industry can continue to support cancer care for the next 12 months and looks at what physicians want, and need, from the industry.
It’s clear that the acute phase of the pandemic had a huge impact on cancer care across Europe. Healthcare services were repurposed to combat COVID-19, surgical procedures postponed, screening programmes paused, and patients avoided healthcare facilities.
...Today's Sponsors
Today's Sponsor